Royal Bank of Canada’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-29,597
Closed -$90K 6808
2024
Q4
$90K Buy
29,597
+490
+2% +$1.49K ﹤0.01% 4934
2024
Q3
$151K Buy
29,107
+665
+2% +$3.45K ﹤0.01% 4603
2024
Q2
$73K Sell
28,442
-66,311
-70% -$170K ﹤0.01% 5075
2024
Q1
$467K Buy
94,753
+5,425
+6% +$26.7K ﹤0.01% 3620
2023
Q4
$786K Buy
89,328
+17,065
+24% +$150K ﹤0.01% 3371
2023
Q3
$830K Buy
72,263
+29,553
+69% +$339K ﹤0.01% 3144
2023
Q2
$1.08M Sell
42,710
-1,103
-3% -$27.9K ﹤0.01% 2941
2023
Q1
$1.41M Sell
43,813
-19,879
-31% -$640K ﹤0.01% 2763
2022
Q4
$1.18M Buy
63,692
+11,320
+22% +$209K ﹤0.01% 2968
2022
Q3
$1.41M Sell
52,372
-21,065
-29% -$569K ﹤0.01% 2740
2022
Q2
$1.01M Buy
73,437
+16,973
+30% +$234K ﹤0.01% 3105
2022
Q1
$1.1M Sell
56,464
-401
-0.7% -$7.82K ﹤0.01% 3139
2021
Q4
$928K Buy
56,865
+15,281
+37% +$249K ﹤0.01% 3423
2021
Q3
$1.16M Buy
41,584
+16,971
+69% +$473K ﹤0.01% 3100
2021
Q2
$730K Sell
24,613
-4,912
-17% -$146K ﹤0.01% 3521
2021
Q1
$824K Sell
29,525
-9,619
-25% -$268K ﹤0.01% 3333
2020
Q4
$1.11M Buy
39,144
+13,842
+55% +$392K ﹤0.01% 2948
2020
Q3
$636K Buy
25,302
+1,080
+4% +$27.1K ﹤0.01% 3224
2020
Q2
$592K Buy
24,222
+42
+0.2% +$1.03K ﹤0.01% 3220
2020
Q1
$358K Sell
24,180
-207
-0.8% -$3.07K ﹤0.01% 3460
2019
Q4
$395K Sell
24,387
-6,658
-21% -$108K ﹤0.01% 3574
2019
Q3
$404K Sell
31,045
-753
-2% -$9.8K ﹤0.01% 3440
2019
Q2
$412K Buy
31,798
+5,068
+19% +$65.7K ﹤0.01% 3456
2019
Q1
$422K Buy
26,730
+2,501
+10% +$39.5K ﹤0.01% 3340
2018
Q4
$488K Sell
24,229
-1,530
-6% -$30.8K ﹤0.01% 3150
2018
Q3
$640K Buy
25,759
+130
+0.5% +$3.23K ﹤0.01% 3171
2018
Q2
$704K Sell
25,629
-867
-3% -$23.8K ﹤0.01% 2985
2018
Q1
$816K Buy
26,496
+874
+3% +$26.9K ﹤0.01% 2791
2017
Q4
$916K Sell
25,622
-1,699
-6% -$60.7K ﹤0.01% 2684
2017
Q3
$753K Buy
27,321
+3,553
+15% +$97.9K ﹤0.01% 2849
2017
Q2
$627K Buy
23,768
+3,637
+18% +$95.9K ﹤0.01% 2885
2017
Q1
$419K Sell
20,131
-609
-3% -$12.7K ﹤0.01% 3201
2016
Q4
$429K Buy
20,740
+1,205
+6% +$24.9K ﹤0.01% 3200
2016
Q3
$317K Buy
19,535
+307
+2% +$4.98K ﹤0.01% 3398
2016
Q2
$261K Sell
19,228
-992
-5% -$13.5K ﹤0.01% 3562
2016
Q1
$353K Buy
20,220
+13,933
+222% +$243K ﹤0.01% 3315
2015
Q4
$214K Buy
6,287
+4,897
+352% +$167K ﹤0.01% 3781
2015
Q3
$41K Sell
1,390
-375
-21% -$11.1K ﹤0.01% 4657
2015
Q2
$57K Buy
1,765
+1,115
+172% +$36K ﹤0.01% 4669
2015
Q1
$13K Sell
650
-251
-28% -$5.02K ﹤0.01% 5045
2014
Q4
$15K Buy
901
+251
+39% +$4.18K ﹤0.01% 4907
2014
Q3
$13K Sell
650
-25,475
-98% -$510K ﹤0.01% 4852
2014
Q2
$888K Buy
26,125
+14,925
+133% +$507K ﹤0.01% 2510
2014
Q1
$353K Buy
+11,200
New +$353K ﹤0.01% 3162